The corporate pharmaceutical model and the legacy of Doha : whither a global consensus on public health governance?
Year of publication: |
2003
|
---|---|
Authors: | Savirimuthu, Joseph |
Published in: |
South Asia economic journal : journal of the Institute of Policy Studies, Sri Lanka and Research and Information System for Developing Countries, India, for the SAARC Research Network. - Los Angeles, Calif. [u.a.] : Sage, ISSN 1391-5614, ZDB-ID 2094316-7. - Vol. 4.2003, 1, p. 73-98
|
Subject: | Welt | World | Gesundheitspolitik | Health policy | Gesundheitswesen | Health care system | Global Governance | Global governance | Globalisierung | Globalization | Pharmaindustrie | Pharmaceutical industry | Arzneimittel | Pharmaceuticals |
-
Re-thinking global and local manufacturing of medical products after COVID-19
Velásquez, Germán, (2020)
-
The partnership prescription : access to HIV/AIDS-related medicines and public-private partnerships
Brown, Sherri A., (2009)
-
WHO decides on the exception? : securitization and emergency governance in global health
Hanrieder, Tine, (2014)
- More ...
-
Savirimuthu, Joseph, (2003)
-
Do Algorithms Dream of 'Data' Without Bodies?
Savirimuthu, Joseph, (2017)
-
ANPR : Code and Rhetorics of Compliance
Parsons, Christopher A., (2013)
- More ...